Communiqués Collegium Pharmaceutical, Inc.

Actions

COLL

US19459J1043

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 04/09/2026			Varia. 5j.	Varia. 1 janv.
23,53 ^USD	-0,72 %		-7,18 %	-49,18 %

13/08	Collegium Pharmaceutical conclut un accord de rachat d'actions accéléré de 50 millions de dollars	MT
06/08	Collegium Pharmaceutical, Inc. révise ses prévisions de résultats pour l'exercice 2026	CI

Communiqués

13/08	Collegium Announces $50 Million Accelerated Share Repurchase Program	GL
06/08	Collegium Pharmaceutical: Q2 Earnings Snapshot	AQ
06/08	Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress	GL
06/08	Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress	AQ
23/07	Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026	GL
23/07	Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026	AQ
20/07	Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston	GL
05/06	Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
27/05	Collegium to Participate in 2026 Jefferies Global Healthcare Conference	GL
12/05	Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics	GL
07/05	Collegium Pharmaceutical : COLL Q1 2026 Earnings Presentation (Pre-Close) FINAL 05-05-26	PU
07/05	Collegium Pharmaceutical: Q1 Earnings Snapshot	AQ
07/05	Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress	GL
23/04	Collegium to Report First Quarter 2026 Financial Results on May 7, 2026	GL
08/04	Collegium to Participate in Upcoming Investor Conferences	GL
08/04	Collegium to Participate in Upcoming Investor Conferences	AQ
20/03	Collegium to Acquire AZSTARYS from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory	AQ
19/03	Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory	GL
19/03	Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory	AQ
05/03	Collegium to Present New Real-World Data at PainConnect 2026	GL
04/03	Collegium Pharmaceutical - Paris Hilton Shares Her Experience with JORNAY PM and Launches New Embrace Your Sparkle, Campaign with Collegium to Empower the ADHD Community	AQ
03/03	Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community	GL
02/03	Collegium to Participate in Upcoming Investor Conferences	GL
26/02	Collegium Pharmaceutical : 25-Q4 - Earnings Presentation FINAL	PU
26/02	Collegium Pharmaceutical: Q4 Earnings Snapshot	AQ